Clinical outcomes of Descemet's membrane endothelial keratoplasty without routine prophylactic peripheral iridotomy

Author:

Mukhija Ritika1ORCID,Quiney Gabriella,Nanavaty Mayank2ORCID

Affiliation:

1. Sussex Eye Hospital

2. University Hospitals Sussex NHS Foundation Trust

Abstract

AbstractObjectivesTo analyze the outcomes and complications of Descemet's Membrane Endothelial Keratoplasty (DMEK) performed without prophylactic peripheral iridotomy (PI).MethodsDesign:Retrospective study.Setting:institutional, tertiary care eye hospitalStudy Population:All patients who underwent DMEK or DMEK combined with phacoemulsification (DMEK triple) for Fuch's Endothelial Dystrophy, using a standardized protocol between Aug 2016 to July 2021, were included. Previous glaucoma surgery, laser PI, aphakia or complicated pseudophakia were excluded.Main Outcome Measures:Primary outcomes: incidence of the pupillary block (PB). Secondary outcomes: graft detachment (GD), rebubbling rates, uncorrected (UCDVA) & best corrected LogMAR distance visual acuity (BCDVA) and endothelial cell loss (ECL) at six months. Data were analyzed using the chi-square test and stepwise backward regression analysis.Results104 eyes of 72 patients were included. Four eyes (3.8%) developed PB. In two of these cases of PB, standard protocol was not followed; in the other two, there was an inadequate release of gas and aqueous on day 1. Significant GD occurred in 7 eyes (6.6%), and rebubbling in theatre was needed in 4 eyes (3.8%). PB, GD and rebubbling rates did not vary with the surgeon, surgery, or tamponade (air or SF6 gas). UCDVA, BCDVA and ECL at 6 months were 0.29±0.31, 0.20±0.28 and 40.46±20.36%, respectively.ConclusionsCompared to previously reported outcomes of DMEK with PI, our results of PI less DMEK using a standardized protocol have a similar incidence of pupillary block, graft detachment, and rebubbling, with comparable visual acuity and endothelial cell loss.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3